Key Stats for Chemours Stock
- Price change for Chemours stock: -7%
- $CC Stock Price as of Aug. 10: $15
- 52-Week High: $29
- $CC Stock Price Target: $22
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
Chemours (CC) stock moved after the company reported a smaller net loss for Q2, even though adjusted earnings came in slightly below expectations.
- The net loss narrowed to $274 million, or $1.81 per share, a clear improvement from the $380 million loss reported a year earlier.
- But adjusted earnings per share landed at $0.42, at par with the estimate and down from $0.58 in last year’s Q2.
- Revenue also came in light at $1.59 billion, about 5% below what analysts expected, as a 4% drop in sales volume outweighed higher pricing and a small currency boost.
- Segment results were mixed. Titanium Technologies revenue rose 1% to $661 million, helped by pricing gains.
- Thermal & Specialized Solutions revenue slipped 1% to $591 million, mainly due to weaker aftermarket demand for cooling refrigerants in North America, though adjusted EBITDA for that segment actually grew 3% thanks to better pricing.
- Advanced Performance Materials saw the steepest decline, with revenue down 6% to $326 million, largely due to a plant line closure, though its Performance Solutions business grew 8% on strength in data centers and semiconductors.
On a more positive note, operating cash flow jumped to $158 million from $93 million a year ago, and free cash flow more than doubled to $114 million.
Alongside earnings, Chemours also launched two new refrigerant products, Opteon ZE and Opteon 515B, aimed at cooling data centers and commercial buildings.
Company leadership said these products are designed to meet rising cooling demands driven by AI infrastructure growth.
Looking ahead, Chemours expects Q3 adjusted EBITDA between $175 million and $205 million, with full-year 2026 sales growth of 1% to 5% and adjusted EBITDA between $775 million and $825 million.
See analysts’ growth forecasts and price targets for Chemours stock (It’s free) >>>
What the Market Is Telling Us About Chemours Stock
The mixed reaction to Chemours stock shows investors weighing a smaller net loss against a genuine earnings and revenue miss.
Cutting the loss by almost 50% year-over-year is meaningful progress, but falling short on both adjusted EPS and sales suggests underlying demand, especially in the stationary air conditioning aftermarket, remains a real challenge.
Still, there are signs of momentum beneath the surface.
Stronger free cash flow, growing Performance Solutions demand tied to AI infrastructure, and the launch of new data center cooling products all point to a company positioning itself for the AI-driven cooling boom.
With net leverage still elevated at around 4.4x, though, investors are likely watching closely to see whether Chemours can convert this growing AI opportunity into steadier, more predictable earnings ahead.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does Chemours Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
